MATTEO MICUCCI

Dr. MATTEO MICUCCI

University of Urbino, Urbino, Marche, Italy
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ECE. Carosati
E. Carosati
PIP. Ioan
P. Ioan
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
FBF. Broccatelli
F. Broccatelli
GCGabriele Cruciani
Gabriele Cruciani
RBR. Budriesi
R. Budriesi
1,4-Dihydropyridines were introduced in the last century for the treatment of coronary diseases. Then medicinal chemists decorated the 1,4-DHP nucleus, the most studied scaffold among L-type calcium channel blockers, achieving diverse activities at several receptors, channels and enzymes. We already described (Ioan et al. Curr. Med. Chem. 2011, 18, 4901-4922) the effects of 1,4-DHPs at ion channels and G-protein coupled receptors. In this paper we continue the analysis of the wide range of biological effects exerted by compounds belonging to this chemical class. In particular, focus is given to the ability of 1,4-DHPs to revert multi drug resistance that, after over 20 years of research, continues to be of great interest. We also describe activities on other targets and the action of 1,4-DHPs against several diseases. Finally, we report and review the interaction of 1,4-DHPs with the hERG channel, transporters and phase I metabolizing enzymes. This work is a starting point for further exploration of the 1,4-DHP core activities on targets, off-targets and antitargets.

5 September 2017 in Diseases
Verified
Journal Article
Open access
PDF file
KZKeti Zeka
Keti Zeka
KRKetan Ruparelia
Ketan Ruparelia
RARandolph Arroo
Randolph Arroo
Roberta BudriesiRoberta Budriesi
Roberta Budriesi
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
The occurrence of atherosclerosis and diabetes is expanding rapidly worldwide. These two metabolic disorders often co-occur, and are part of what is often referred to as the metabolic syndrome. In order to determine future therapies, we propose that molecular mechanisms should be investigated. Once the aetiology of the metabolic syndrome is clear, a nutritional intervention should be assessed. Here we focus on the protective effects of some dietary flavonoids, and their metabolites. Further studies may also pave the way for development of novel drug candidates.

Verified
Journal Article
Open access
PDF file
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
ASAmit Singh
Amit Singh
Ramesh KumarRamesh Kumar
Ramesh Kumar
CCCourtney Croley
Courtney Croley
APAbhay Pandey
Abhay Pandey
Anupam BishayeeAnupam Bishayee
Anupam Bishayee
A balanced metabolic profile is essential for normal human physiological activities. Disproportions in nutrition give rise to imbalances in metabolism that are associated with aberrant immune function and an elevated risk for inflammatory-associated disorders. Inflammation is a complex process, and numerous mediators affect inflammation-mediated disorders. The available clinical modalities do not effectively address the underlying diseases but rather relieve the symptoms. Therefore, novel targeted agents have the potential to normalize the metabolic system and, thus, provide meaningful therapy to the underlying disorder. In this connection, polyphenols, the well-known and extensively studied phytochemical moieties, were evaluated for their effective role in the restoration of metabolism via various mechanistic signaling pathways. The various flavonoids that we observed in this comprehensive review interfere with the metabolic events that induce inflammation. The mechanisms via which the polyphenols, in particular flavonoids, act provide a promising treatment option for inflammatory disorders. However, detailed clinical studies of such molecules are required to decide their clinical fate.

30 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RARita Aldini
Rita Aldini
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
MCMonica Cevenini
Monica Cevenini
RFRomana Fato
Romana Fato
CBChristian Bergamini
Christian Bergamini
Roberta BudriesiRoberta Budriesi
Roberta Budriesi
Phytosterols, besides hypocholesterolemic effect, present anti-inflammatory properties. Little information is available about their efficacy in Inflammatory Bowel Disease (IBD). Therefore, we have evaluated the effect of a mixture of phytosterols on prevention/induction/remission in a murine experimental model of colitis. Phytosterols were administered x os before, during and after colitis induction with Dextran Sodium Sulfate (DSS) in mice. Disease Activity Index (DAI), colon length, histopathology score, 18F-FDG microPET, oxidative stress in the intestinal tissue (ileum and colon) and gallbladder ileum and colon spontaneous and carbachol (CCh) induced motility, plasma lipids and plasma, liver and biliary bile acids (BA) were evaluated. A similar longitudinal study was performed in a DSS colitis control group. Mice treated with DSS developed severe colitis as shown by DAI, colon length, histopathology score, 18F-FDG microPET, oxidative stress. Both spontaneous and induced ileal and colonic motility were severely disturbed. The same was observed with gallbladder. DSS colitis resulted in an increase in plasma cholesterol, and a modification of the BA pattern. Phytosterols feeding did not prevent colitis onset but significantly reduced the severity of the disease and improved clinical and histological remission. It had strong antioxidant effects, almost restored colon, ileal and gallbladder motility. Plasmatic levels of cholesterol were also reduced. DSS induced a modification in the BA pattern consistent with an increase in the intestinal BA deconjugating bacteria, prevented by phytosterols. Phytosterols seem a potential nutraceutical tool for gastrointestinal inflammatory diseases, combining metabolic systematic and local anti-inflammatory effects.

1 November 2011 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PIP. Ioan
P. Ioan
ECE. Carosati
E. Carosati
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
GCGabriele Cruciani
Gabriele Cruciani
FBF. Broccatelli
F. Broccatelli
RBR. Budriesi
R. Budriesi
Since the pioneering studies of Fleckenstein and co-workers, L-Type Calcium Channel (LTCC) blockers have attracted large interest due to their effectiveness in treating several cardiovascular diseases. Medicinal chemists achieved high potency and tissue selectivity by decorating the 1-4-DHP nucleus, the most studied scaffold among LTCC blockers. Nowadays it is clear that the 1,4-DHP nucleus is a privileged scaffold since, when appropriately substituted, it can selectively modulate diverse receptors, channels and enzymes. Therefore, the 1,4-DHP scaffold could be used to treat various diseases by a single-ligand multi-target approach. In this review, we describe the structure-activity relationships of 1,4-DHPs at ion channels, G-protein coupled receptors, and outline the potential for future therapeutic applications.

11 July 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
ESEmanuele-Salvatore Scarpa
Emanuele-Salvatore Scarpa
AAAntonella Antonelli
Antonella Antonelli
GBGiancarlo Balercia
Giancarlo Balercia
ESEmanuele Salvatore Scarpa
Emanuele Salvatore Scarpa
Filippo MaggiFilippo Maggi
Filippo Maggi
MATTEO MICUCCIMATTEO MICUCCI
MATTEO MICUCCI
Polyphenols are natural bioactives occurring in medicinal and aromatic plants and food and beverages of plant origin. Compared with conventional therapies, plant-derived phytochemicals are more affordable and accessible and have no toxic side effects. Thus, pharmaceutical research is increasingly inclined to discover and study new and innovative natural molecules for the treatment of several chronic human diseases, like type 2 diabetes mellitus (T2DM) and osteoporosis. These pathological conditions are characterized by a chronic inflammatory state and persistent oxidative stress, which are interconnected and lead to the development and worsening of these two health disorders. Oral nano delivery strategies have been used to improve the bioavailability of polyphenols and to allow these natural molecules to exert their antioxidant, anti-inflammatory, anti-diabetic, and pro-osteogenic biological activities in in vivo experimental models and in patients. Polyphenols are commonly used in the formulations of nutraceuticals, which can counteract the detrimental effects of T2DM and osteoporosis pathologies. This review describes the polyphenols that can exert protective effects against T2DM and osteoporosis through the modulation of specific molecular markers and pathways. These bioactives could be used as adjuvants, in combination with synthetic drugs, in the future to develop innovative therapeutic strategies for the treatment of T2DM and osteoporosis.